Centene Corporation

BIT:1CNC Stock Report

Market Cap: €28.3b

Centene Valuation

Is 1CNC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of 1CNC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: 1CNC (€55.66) is trading below our estimate of future cash flow value (€173.03)

Significantly Below Future Cash Flow Value: 1CNC is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1CNC?

Key metric: As 1CNC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 1CNC. This is calculated by dividing 1CNC's market cap by their current revenue.
What is 1CNC's PS Ratio?
PS Ratio0.2x
SalesUS$178.33b
Market CapUS$32.69b

Price to Sales Ratio vs Peers

How does 1CNC's PS Ratio compare to its peers?

The above table shows the PS ratio for 1CNC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.3x
AMP Amplifon
1.2x5.44%€2.8b
HUM Humana
0.3x8.04%US$43.6b
DIA DiaSorin
3.2x6.24%€3.7b
ELV Elevance Health
0.4x1.95%US$92.2b
1CNC Centene
0.2x3.63%€32.7b

Price-To-Sales vs Peers: 1CNC is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (1.3x).

Historical Price to Sales Ratio

Historical Price to Sales Ratio compares a stock's price to its sales over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Sales Ratio vs Industry

How does 1CNC's PS Ratio compare vs other companies in the European Healthcare Industry?

9 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.0.7x5.2%
1CNC Centene
 0.2x3.63%US$32.69b
1CNC 0.2xIndustry Avg. 0.7xNo. of Companies19PS00.81.62.43.24+
9 CompaniesEstimated GrowthMarket Cap
Industry Avg.0.7x19.5%
1CNC Centene
 0.2x66.93%US$32.69b
No more companies

Price-To-Sales vs Industry: 1CNC is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Healthcare industry average (0.8x).

Price to Sales Ratio vs Fair Ratio

What is 1CNC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1CNC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio1.4x

Price-To-Sales vs Fair Ratio: 1CNC is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (1.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1CNC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€55.66
€53.21
-4.40%
17.98%€69.38€34.69n/a17
Jun ’27€52.84
€51.66
-2.24%
18.93%€68.81€34.40n/a17
May ’27€45.30
€45.33
+0.056%
14.55%€59.73€34.13n/a17
Apr ’27€29.03
€37.49
+29.18%
20.26%€60.79€27.79n/a17
Mar ’27€37.26
€37.57
+0.82%
20.74%€59.29€27.10n/a17
Feb ’27€36.10
€36.40
+0.82%
21.83%€58.06€26.54n/a17
Jan ’27€35.27
€34.52
-2.12%
21.42%€59.79€27.33n/a17
Dec ’26€32.89
€34.66
+5.37%
22.76%€60.74€24.30n/a17
Nov ’26€30.15
€33.27
+10.37%
25.23%€60.73€21.69n/a17
Oct ’26€30.43
€28.88
-5.08%
31.30%€59.58€20.43n/a16
Sep ’26€25.60
€29.54
+15.40%
31.76%€59.82€20.51n/a16
Aug ’26€22.39
€30.84
+37.76%
30.23%€60.59€20.77n/a16
Jul ’26€48.70
€64.89
+33.24%
12.61%€78.03€51.74n/a17
Jun ’26€50.06
€68.75
+37.33%
12.08%€80.99€53.70€52.8416
May ’26€52.31
€68.95
+31.80%
11.80%€81.48€54.03€45.3016
Apr ’26€56.14
€72.67
+29.45%
12.79%€85.96€48.99€29.0317
Mar ’26€55.31
€75.81
+37.06%
12.79%€89.67€51.10€37.2617
Feb ’26€61.99
€77.31
+24.72%
12.60%€90.50€50.60€36.1017
Jan ’26€57.51
€76.57
+33.15%
12.33%€89.70€50.15€35.2717
Dec ’25€57.11
€78.00
+36.57%
10.42%€90.68€63.00€32.8917
Nov ’25€58.78
€76.98
+30.97%
9.73%€87.67€60.90€30.1517
Oct ’25€67.80
€77.56
+14.39%
8.07%€87.29€64.79€30.4317
Sep ’25€71.08
€77.61
+9.18%
8.54%€88.48€66.81€25.6017
Aug ’25€69.84
€78.73
+12.73%
7.91%€88.04€68.58€22.3917
Jul ’25€61.73
€81.50
+32.03%
9.25%€102.44€70.78€48.7018
Jun ’25€64.87
€81.65
+25.86%
9.73%€101.40€70.06€50.0618
€52.26
Fair Value
6.5% overvalued intrinsic discount
17
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/10 12:29
End of Day Share Price 2026/06/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Centene Corporation is covered by 32 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Hua HaBaird
Andrew MokBarclays